Colonocyte mitochondrial energy metabolism

Colonocyte mitochondrial energy metabolism refers to the specialized metabolic pathway in which colonic epithelial cells utilize microbiota-derived short-chain fatty acids, primarily butyrate, as their main energy source [NIH]. This process accounts for over 70% of the oxygen consumption in the healthy colonic mucosa and is vital for maintaining the epithelial barrier and preventing inflammation [PubMed]. A defect in this metabolic pathway, known as the 'energy deficiency' hypothesis, is a key factor in the development of ulcerative colitis, where colonocytes fail to oxidize butyrate despite its availability [PubMed]. Therapeutic approaches focus on restoring this metabolism using butyrate supplements, prodrugs like tributyrin, or probiotics that modulate the gut microbiota to increase butyrate production [Frontiers in Microbiology]. Additionally, proteins such as Keratin 8 and the transporter MCT1 are essential for the structural and functional integrity of mitochondria in these cells, making them indirect targets for maintaining colonic health [NIH]. The metabolism is also influenced by environmental factors like ammonia, which can inhibit mitochondrial respiration and contribute to epithelial damage [Frontiers in Microbiology]. In the context of colorectal cancer, this metabolism is often altered as cells shift toward glycolysis, a phenomenon that drugs like Urolithin A may counteract by promoting mitochondrial health and mitophagy [PubMed]. Overall, targeting this metabolic axis represents a promising strategy for treating chronic intestinal inflammatory conditions.

Other names

Butyrate oxidation pathwayColonic mitochondrial metabolismColonocyte energy metabolismButyrate-mitochondria axis

Restoration of mitochondrial energy production through the provision of short-chain fatty acid substrates, upregulation of oxidation enzymes via PPAR-gamma activation, or stabilization of mitochondrial function and dynamics.